Selleck Chemicals - Model A2046 -Risankizumab (anti-IL-23)

Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.